Tissue plasminogen activator (t-PA) is the only treatment currently proven to benefit stroke victims, but no physician guide to its safe and proper use exists. In Thrombolytic Therapy for Stroke, the world's leading experts detail the basic rationale, scientific evidence, and tr…
TPA for Stroke: The Story of a Controversial Drug explains the drug's beginnings within pharmaceutical giant Genentech, and its eventual marginalization due to a convergence of unfortunate political, fiscal, and medical circumstances.
Without warning stroke can paralyze, blind, or kill. Some victims recover, but many do not and may even suffer another disabling or fatal attack. The drug known as tPA can drastically reduce the long-term disability associated with stroke, but despite its near-miraculous capabil…